A new Northwestern Medicine study has uncovered how a key enzyme in mitochondria can function as both a cancer suppressor and cancer promoter.
Northwestern scientists have discovered how certain genetic mutations can weaken protein “quality control,” identifying a pathway that may contribute to neurodegenerative diseases.
In a new clinical exposure program, doctoral students in the Driskill Graduate Program in Life Sciences partner with clinicians at Lurie Children’s Hospital to forge connections between basic and clinical research efforts.
A combination of idelalisib and rituximab is an effective and safe treatment for patients with relapsed chronic lymphocytic leukemia, according to the results of a phase III clinical trial.
Northwestern has established a new Institute for Global Health that aims to improve health in middle- and lower-income countries around the world and deepens the medical school’s commitment to solving health problems worldwide.
Northwestern Medicine scientists have identified the critical role that a specific ion channel plays in the activity of brain cells called astrocytes.
A drug called regorafenib significantly improved progression-free survival in patients with metastatic osteosarcoma, according to a study published in the Journal of Clinical Oncology.
Cholesterol levels in U.S. youth have improved from 1999 to 2016, but only half of children and adolescents are in the ideal range, according to a new study published in JAMA.
An artificial intelligence system was able to detect malignant lung cancer nodules on CT scans as well as — or better — than expert radiologists, according to a new study.
Waiting to begin treatments for diabetic macular edema until patients experience vision loss resulted in similar outcomes compared to starting treatments prior to vision loss, according to a recent study published in JAMA.